Zydus Cadila said it received six-month exclusivity for the sale of generic tofacitinib, a drug that has annual sales of over $2 billion in the US. The exclusivity was provided by the US FDA, since Cadila Healthcare was the first to file an abbreviated new drug application or ANDA for the drug. An ANDA is […]
Cadila Healthcare said it has launched a generic blood thinning medication, Enoxaparin Sodium Injection, in the US, where the drug has annual sales of around $513 mn, or around Rs 3,800 cr. With this, the company has become the first Indian firm to launch a generic version of the drug in that market. Enoxaparin Sodium […]
Dr Reddy’s Laboratories, one of India’s largest pharmaceutical manufacturers, commercially launched 2DG COVID-19 treatment today, starting with the bigger cities. The drug, formulated by DRDO’s Institute of Nuclear Medicine & Allied Sciences in collaboration with Dr Reddy’s, is supposed to reduce the viral load in patients suffering from COVID-19. The drug, 2-deoxy-D-glucose, is supposed to […]
Zydus Cadila, the pharmaceutical arm of the Zydus group, said it has launched a next-generation breast cancer drug in India at a fraction of its existing cost. The drug, Trastuzumab Emtansine, is considered the first targeted chemotherapy drug for breast cancer as it directs the cytotoxic activity at cancer cells by using a known biomarker. […]
India-based pharmaceuticals maker Glenmark Pharma has launched a generic version of a popular kidney cancer drug priced 96% lower than the branded version in India. Pfizer is the innovator of Sunitinib. Glenmark said its drug is launched at a price that is approximately 96% lower than the MRP of the innovator brand. Glenmark’s prices are […]
